THNR vs. HELX ETF Comparison

Comparison of Amplify Weight Loss Drug & Treatment ETF (THNR) to Franklin Genomic Advancements ETF (HELX)
THNR

Amplify Weight Loss Drug & Treatment ETF

THNR Description

The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists (glucagon-like peptide) seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$26.27

Average Daily Volume

10,610

Number of Holdings *

7

* may have additional holdings in another (foreign) market
HELX

Franklin Genomic Advancements ETF

HELX Description Seeks capital appreciation by investing in innovative companies related to genomic-based technologies designed to enhance the quality of life. Provides access to companies benefitting from or facilitating the use of new research including DNA sequencing, gene editing and personalized medicine Uses bottom-up fundamental research conducted by dedicated, industry-specific analysts to identify disruptive business models at the right stage for investment Actively managed by a seasoned portfolio management team that is based in Silicon Valley and has a long history of investing in the craft of innovation

Grade (RS Rating)

Last Trade

$31.58

Average Daily Volume

1,217

Number of Holdings *

49

* may have additional holdings in another (foreign) market
Performance
Period THNR HELX
30 Days 2.35% -1.46%
60 Days 1.46%
90 Days -1.40%
12 Months 6.17%
2 Overlapping Holdings
Symbol Grade Weight in THNR Weight in HELX Overlap
LLY A 15.58% 4.98% 4.98%
TMO D 4.72% 4.6% 4.6%
THNR Overweight 5 Positions Relative to HELX
Symbol Grade Weight
NVO B 14.9%
AMGN B 5.57%
PFE C 5.32%
MRK C 5.02%
CTLT B 4.75%
THNR Underweight 47 Positions Relative to HELX
Symbol Grade Weight
MEDP C -7.39%
VRTX B -5.55%
REGN B -5.33%
DHR D -4.93%
KRYS B -4.44%
NTRA B -3.45%
AZN C -2.71%
MRNA D -2.6%
IONS B -2.54%
BRKR F -2.4%
CDNS B -2.34%
CTVA D -2.08%
CRL F -2.07%
SRPT C -2.0%
A D -2.0%
INSM A -1.92%
RCKT F -1.84%
QGEN D -1.8%
ICLR B -1.78%
ALNY A -1.67%
UTHR B -1.59%
BNTX F -1.31%
TWST B -1.29%
EXAS D -1.12%
FDMT D -1.1%
VYGR F -1.1%
AZTA D -1.04%
IQV D -1.04%
NBIX C -0.96%
TECH D -0.94%
NTLA F -0.93%
BBIO D -0.9%
RARE D -0.89%
BEAM D -0.85%
CRSP F -0.76%
LGND B -0.69%
RXRX F -0.67%
CDMO D -0.56%
RGEN F -0.49%
AVTR D -0.44%
BIO D -0.43%
SLP F -0.43%
ARE C -0.29%
BMY F -0.25%
DVAX D -0.21%
VCYT C -0.16%
OLK A -0.13%
Compare ETFs